Terms: = Endocrine gland cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
177 results:
1. hmga2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells.
Luo Z; Zheng Q; Ye S; Li Y; Chen J; Fan C; Chen J; Lei Y; Liao Q; Xi Y
Cell Death Dis; 2024 Mar; 15(3):220. PubMed ID: 38493165
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/hmga2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract] [Full Text] [Related]
3. LINC02454 promotes thyroid carcinoma progression via upregulating hmga2 through CREB1.
Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
[TBL] [Abstract] [Full Text] [Related]
4. CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells.
Jin S; Yong H; Liu Y; Bao W
Adv Med Sci; 2023 Sep; 68(2):409-416. PubMed ID: 37837800
[TBL] [Abstract] [Full Text] [Related]
5. Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma.
Oflas D; Canaz F; Özer İ; Demir L; Çolak E
Turk J Gastroenterol; 2023 Oct; 34(10):1014-1024. PubMed ID: 37787719
[TBL] [Abstract] [Full Text] [Related]
6. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract] [Full Text] [Related]
7. cancer vaccines are back, revitalized.
Vonderheide RH
Med; 2023 Jul; 4(7):395-397. PubMed ID: 37453413
[TBL] [Abstract] [Full Text] [Related]
8. Unraveling the Roles of miR-204-5p and hmga2 in Papillary Thyroid cancer Tumorigenesis.
Van Branteghem C; Augenlicht A; Demetter P; Craciun L; Maenhaut C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445942
[TBL] [Abstract] [Full Text] [Related]
9. liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian cancer Growth.
Kang X; Wang Q; Wu S; Wang C; Annaji M; Huang CH; Shen J; Chen P; Babu RJ
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238613
[TBL] [Abstract] [Full Text] [Related]
10. [circ_0092315 Promotes Proliferation and Invasion of Papillary Thyroid Carcinoma Cells
Ke SH; Kong CX; Xu Y; Peng C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):16-21. PubMed ID: 36861149
[TBL] [Abstract] [Full Text] [Related]
11. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting hmga2.
Song Z; Liao C; Yao L; Xu X; Shen X; Tian S; Wang S; Xing F
Cancer Gene Ther; 2023 Apr; 30(4):596-607. PubMed ID: 36494581
[TBL] [Abstract] [Full Text] [Related]
12. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
13. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
[TBL] [Abstract] [Full Text] [Related]
14. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis.
Chen L; Zhang X; Zhang Q; Zhang T; Xie J; Wei W; Wang Y; Yu H; Zhou H
Front Immunol; 2022; 13():1022420. PubMed ID: 36275722
[TBL] [Abstract] [Full Text] [Related]
15. Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in Ovarian cancer Cells.
Gandham SK; Attarwala HZ; Amiji MM
Mol Pharm; 2022 Nov; 19(11):4067-4079. PubMed ID: 36226722
[TBL] [Abstract] [Full Text] [Related]
16. Preparation and In Vitro Evaluation of Thermosensitive liposomes Targeting Ovarian cancer.
Wang X; Wang F; Li S; Yin G; Pu X
Curr Drug Deliv; 2022 Aug; 19(9):940-948. PubMed ID: 35319368
[TBL] [Abstract] [Full Text] [Related]
17. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
Ding C; Shi T; Wu G; Man J; Han H; Cui Y
Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of high mobility group A2 (hmga2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic hmga2 expression.
Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
[TBL] [Abstract] [Full Text] [Related]
19. Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens.
Wang Y; McKelvey BA; Liu Z; Rooper L; Cope LM; Zeiger MA; Umbricht CB
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2983-2991. PubMed ID: 34165589
[TBL] [Abstract] [Full Text] [Related]
20. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic hmga2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract] [Full Text] [Related]
[Next]
